Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BMC Cancer|December 24, 2022
Finding My Way-Advanced: can a web-based psychosocial intervention improve the mental quality of life for women with metastatic breast cancer vs attention-control? Study protocol of a randomised controlled trialLisa Beatty, Emma Kemp, Phyllis Butow, et al.
The Lancet. Oncology|March 6, 2025
Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61-20; Neo-N): a non-comparative, open-label, randomised, phase 2 trialNicholas Zdenkowski, Marion J J Kuper-Hommel, Samuel M Niman, et al.
Breast (Edinburgh, Scotland)|November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratioClara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.
Lancet (London, England)|December 8, 2023
Postoperative radiotherapy omission in selected patients with early breast cancer following preoperative breast MRI (PROSPECT): primary results of a prospective two-arm studyGregory Bruce Mann, Anita Rohini Skandarajah, Nicholas Zdenkowski, et al.
BMJ Open|April 20, 2024
Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT projectShelley Potter, Kerry Avery, Rosina Ahmed, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 26, 2024
Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic reviewMichael Jiang, Kerry Avery, Rosina Ahmed, et al.
Annals of Translational Medicine|January 20, 2023
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort studyMeirong Zhou, Shouman Wang, Nengbin Wan, et al.
NPJ Breast Cancer|October 29, 2025
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trialsShelley Potter, Kerry Avery, Rosina Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.
Psycho-Oncology|April 7, 2022
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysisYvonne L Luigjes-Huizer, Nina M Tauber, Gerry Humphris, et al.
Pageof 5